日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dysfunction of motor cortices in Parkinson's disease

帕金森病运动皮层功能障碍

Chu, Hong-Yuan; Smith, Yoland; Lytton, William W; Grafton, Scott; Villalba, Rosa; Masilamoni, Gunasingh; Wichmann, Thomas

Phosphodiesterase 9 inhibition prolongs the antiparkinsonian action of l-DOPA in parkinsonian non-human primates

磷酸二酯酶 9 抑制剂可延长左旋多巴在患有帕金森病的非人灵长类动物中的抗帕金森病作用

Masilamoni, Gunasingh J; Sinon, Christopher G; Kochoian, Brik A; Singh, Arun; McRiner, Andrew J; Leventhal, Liza; Papa, Stella M

Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series.

在帕金森病猴模型中,小胶质细胞、炎症和肠道菌群反应:病例系列研究

Joers Valerie, Masilamoni Gunasingh, Kempf Doty, Weiss Alison R, Rotterman Travis M, Murray Benjamin, Yalcin-Cakmakli Gul, Voll Ronald J, Goodman Mark M, Howell Leonard, Bachevalier Jocelyne, Green Stefan J, Naqib Ankur, Shaikh Maliha, Engen Phillip A, Keshavarzian Ali, Barnum Christopher J, Nye Jonathon A, Smith Yoland, Tansey Malú G

Effects of a novel phosphodiesterase 10A inhibitor in non-human primates: A therapeutic approach for schizophrenia with improved side effect profile

新型磷酸二酯酶10A抑制剂在非人灵长类动物中的作用:一种副作用更小的精神分裂症治疗方法

Masilamoni, Gunasingh J; Uthayathas, Subramanian; Koenig, Gerhard; Leventhal, Liza; Papa, Stella M

Phosphodiesterase 10A inhibitor MP-10 effects in primates: comparison with risperidone and mechanistic implications

磷酸二酯酶10A抑制剂MP-10在灵长类动物中的作用:与利培酮的比较及其机制意义

Uthayathas, Subramaniam; Masilamoni, Gunasingh J; Shaffer, Christopher L; Schmidt, Christopher J; Menniti, Frank S; Papa, Stella M

Sequestration of toxic oligomers by HspB1 as a cytoprotective mechanism

HspB1通过螯合毒性寡聚体发挥细胞保护作用

Ojha, Juhi; Masilamoni, Gunasingh; Dunlap, David; Udoff, Ross A; Cashikar, Anil G